CD4 T Cells Reactive to Hybrid Insulin Peptides Are Indicators of Disease Activity in the NOD Mouse.
Rocky L BakerBraxton L JamisonTimothy A WilesRobin S LindsayGene BarbourBrenda BradleyThomas DelongRachel S FriedmanMaki NakayamaKathryn HaskinsPublished in: Diabetes (2018)
We recently established that hybrid insulin peptides (HIPs), formed in islet β-cells by fusion of insulin C-peptide fragments to peptides of chromogranin A or islet amyloid polypeptide, are ligands for diabetogenic CD4 T-cell clones. The goal of this study was to investigate whether HIP-reactive T cells were indicative of ongoing autoimmunity. MHC class II tetramers were used to investigate the presence, phenotype, and function of HIP-reactive and insulin-reactive T cells in NOD mice. Insulin-reactive T cells encounter their antigen early in disease, but they express FoxP3 and therefore may contribute to immune regulation. In contrast, HIP-reactive T cells are proinflammatory and highly diabetogenic in an adoptive transfer model. Because the frequency of antigen-experienced HIP-reactive T cells increases over progression of disease, they may serve as biomarkers of autoimmune diabetes.
Keyphrases
- type diabetes
- glycemic control
- disease activity
- rheumatoid arthritis
- total hip arthroplasty
- cardiovascular disease
- magnetic resonance imaging
- magnetic resonance
- stem cells
- multiple sclerosis
- ankylosing spondylitis
- juvenile idiopathic arthritis
- oxidative stress
- rheumatoid arthritis patients
- immune response
- cell therapy
- adipose tissue
- dendritic cells
- insulin resistance
- computed tomography
- skeletal muscle
- weight loss
- celiac disease